| scholarly article | Q13442814 |
| P2093 | author name string | Chunying Zhao | |
| Zhongmin Alex Ma | |||
| Feng Zheng | |||
| Helen Vlassara | |||
| Weijing Cai | |||
| Zhengshan Zhao | |||
| Xu Hannah Zhang | |||
| P2860 | cites work | Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products | Q47231228 |
| Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. | Q54453992 | ||
| Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice | Q56971868 | ||
| Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages | Q71387874 | ||
| The Use of Aminoguanidine, a Selective iNOS Inhibitor, to Evaluate the Role of Nitric Oxide in the Development of Autoimmune Diabetes | Q71544634 | ||
| Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase | Q72370715 | ||
| Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases | Q72462338 | ||
| Standardizing the immunological measurement of advanced glycation endproducts using normal human serum | Q73782698 | ||
| Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products | Q74450189 | ||
| Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice | Q77730593 | ||
| Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose | Q77795060 | ||
| Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy | Q24682750 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas | Q28251843 | ||
| Identification of arginine as a precursor of endothelium-derived relaxing factor | Q33672060 | ||
| Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance | Q34050555 | ||
| beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. | Q34197343 | ||
| Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. | Q34363859 | ||
| Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm | Q34370210 | ||
| Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy | Q34388076 | ||
| Diabetes and advanced glycation endproducts | Q34521835 | ||
| Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions | Q34527799 | ||
| Islet beta cell failure in type 2 diabetes | Q34698810 | ||
| Insulin resistance and pancreatic beta cell failure | Q34698828 | ||
| Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets | Q34796756 | ||
| Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine | Q35691202 | ||
| Glycoxidation and diabetic complications: modern lessons and a warning? | Q35813624 | ||
| Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction | Q36088078 | ||
| Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase | Q36364369 | ||
| Lipid advanced glycosylation: pathway for lipid oxidation in vivo | Q36412583 | ||
| Diabetes and advanced glycoxidation end products. | Q36491515 | ||
| Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology. | Q36555287 | ||
| Nitric oxide regulation of mitochondrial oxygen consumption II: Molecular mechanism and tissue physiology | Q36747857 | ||
| Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling | Q37598066 | ||
| Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus | Q39899179 | ||
| Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. | Q40348831 | ||
| Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide | Q40541205 | ||
| Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells | Q40702746 | ||
| Aminoguanidine exerts a beta-cell function-preserving effect in high glucose-cultured beta-cells (INS-1). | Q40710854 | ||
| Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function | Q41020720 | ||
| Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function | Q42528402 | ||
| Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells | Q42528768 | ||
| Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction | Q42801423 | ||
| Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. | Q44043194 | ||
| Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition | Q44114881 | ||
| Effects of a diet rich in advanced glycation end products in the rat remnant kidney model | Q44337954 | ||
| Monolayer Culture of Adult Rat Pancreatic Islets on Extracellular Matrix: Modulation of B-Cell Function by Chronic Exposure to High Glucose* | Q44381039 | ||
| Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice | Q44453007 | ||
| Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice | Q44474816 | ||
| Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice | Q44631836 | ||
| Historical perspective of the Maillard reaction in food science | Q46613054 | ||
| Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake | Q46620647 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| adenosine triphosphate | Q80863 | ||
| preproinsulin | Q7240673 | ||
| glycobiology | Q899224 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 2569-2576 | |
| P577 | publication date | 2009-02-26 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis | |
| P478 | volume | 150 |
| Q37003623 | AGE restriction in diabetes mellitus: a paradigm shift |
| Q33886522 | AGEs decrease insulin synthesis in pancreatic β-cell by repressing Pdx-1 protein expression at the post-translational level |
| Q47166089 | Activation of NLRP3 Inflammasome by Advanced Glycation End Products Promotes Pancreatic Islet Damage |
| Q34591712 | Acute exposure to a precursor of advanced glycation end products induces a dual effect on the rat pancreatic islet function. |
| Q37231780 | Advanced Glycation End Products Impair Glucose-Stimulated Insulin Secretion of a Pancreatic β-Cell Line INS-1-3 by Disturbance of Microtubule Cytoskeleton via p38/MAPK Activation |
| Q37362121 | Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia |
| Q37520014 | Advanced glycation end products (AGE) and diabetes: cause, effect, or both? |
| Q35255473 | Advanced glycation end products and oxidative stress in type 2 diabetes mellitus |
| Q35227180 | Advanced glycation end products are direct modulators of β-cell function |
| Q53250601 | Advanced glycation end products downregulate glucokinase in mice. |
| Q35647771 | Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice. |
| Q45387198 | Advanced glycation end products impair glucose-induced insulin secretion from rat pancreatic β-cells |
| Q34542291 | Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption |
| Q34127184 | Age-related impairment of pancreatic Beta-cell function: pathophysiological and cellular mechanisms |
| Q49210690 | Age-related oxidative changes in pancreatic islets are predominantly located in the vascular system. |
| Q36567296 | An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes |
| Q41690287 | Chronic Exposure to Proline Causes Aminoacidotoxicity and Impaired Beta-Cell Function: Studies In Vitro |
| Q36571129 | Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial. |
| Q85893933 | Dual effect of advanced glycation end products in pancreatic islet apoptosis |
| Q55079458 | Effects of a Low Advanced Glycation End Products Diet on Insulin Levels: The Feasibility of a Crossover Comparison Test. |
| Q28752234 | Evolution in health and medicine Sackler colloquium: Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition |
| Q35774014 | FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2). |
| Q38458872 | FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice |
| Q90197658 | Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion |
| Q41962875 | Glycated albumin suppresses glucose-induced insulin secretion by impairing glucose metabolism in rat pancreatic β-cells |
| Q24610496 | Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics) |
| Q41037085 | High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report. |
| Q35632861 | Hyperinsulinism and diabetes: genetic dissection of beta cell metabolism-excitation coupling in mice |
| Q35036279 | Hyperuricemia causes pancreatic β-cell death and dysfunction through NF-κB signaling pathway |
| Q28582485 | Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells |
| Q38736612 | Inhibition of tumor suppressor p53 preserves glycation-serum induced pancreatic beta-cell demise |
| Q34674484 | Low-carbohydrate diet scores and risk of type 2 diabetes in men. |
| Q36796216 | Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift |
| Q34153508 | Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? |
| Q90886112 | Melatonin improves hyperglycemia induced damages in rat brain |
| Q47978105 | Methylglyoxal treatment in lactating mothers leads to type 2 diabetes phenotype in male rat offspring at adulthood. |
| Q35550591 | Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus |
| Q87939347 | Modified Si-Miao-San ameliorates pancreatic B cell dysfunction by inhibition of reactive oxygen species-associated inflammation through AMP-kinase activation |
| Q39327224 | Monacolin K and monascin attenuated pancreas impairment and hyperglycemia induced by advanced glycation endproducts in BALB/c mice. |
| Q36300685 | Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. |
| Q34592806 | PPARγ activation attenuates glycated-serum induced pancreatic beta-cell dysfunction through enhancing Pdx1 and Mafa protein stability |
| Q47575059 | Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction. |
| Q33993824 | Protection of pancreatic beta-cells by group VIA phospholipase A(2)-mediated repair of mitochondrial membrane peroxidation |
| Q26828574 | Purinergic signalling and diabetes |
| Q26853024 | Purinergic signalling in the pancreas in health and disease |
| Q38950436 | Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis. |
| Q37268198 | Receptor for advanced glycation endproducts signaling cascades are activated in pancreatic fibroblasts, but not in the INS1E insulinoma cell line: Are mesenchymal cells major players in chronic inflammation? |
| Q27021921 | Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts |
| Q38078014 | Redox-inflammatory synergy in the metabolic syndrome |
| Q35808979 | Sesamin Ameliorates Advanced Glycation End Products-Induced Pancreatic β-Cell Dysfunction and Apoptosis. |
| Q42226832 | The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications |
| Q52583445 | The Receptor for Advanced Glycation Endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and Exploiting Common Ground for Novel Amyloidosis Therapies. |
| Q33849438 | The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liver |
| Q26995759 | The role of peroxidation of mitochondrial membrane phospholipids in pancreatic β -cell failure |